Advertisement
A conference call to review the results will begin at 2:00 p.m. PDT (5:00p.m. EDT) and will be hosted by Euan S. Thomson, Ph.D., president and chiefexecutive officer and Holly Grey, senior vice president finance and interimprincipal financial officer.
Advertisement
The conference call dial-in numbers are 1-866-379-2019 (USA) or1-706-634-1525 (International), Conference ID: 68362601. In addition, adial-up replay of the conference call will be available beginning October 29,2008 at 5:00 p.m. PDT (8:00 p.m. EDT) and ending on November 1, 2008. Thereplay telephone number is 1-800-642-1687 (USA) or 1-706-645-9291(International), Conference ID: 68362601.
A live webcast of the call will also be available from the InvestorRelations section of the corporate Web site at http://www.accuray.com. Awebcast replay can be accessed on the corporate Web site beginning Wednesday,October 29, 2008 at approximately 5:00 p.m. PDT (8:00 p.m. EDT). The replaywill remain available until Accuray announces its results for the secondquarter of fiscal 2009, ending December 27, 2008.
About the CyberKnife(R) Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world's only roboticradiosurgery system designed to treat tumors anywhere in the bodynon-invasively. Using continual image guidance technology and computercontrolled robotic mobility, the CyberKnife System automatically tracks,detects and corrects for tumor and patient movement in real-time throughoutthe treatment. This enables the CyberKnife System to deliver high-doseradiation with pinpoint precision, which minimizes damage to surroundinghealthy tissue and eliminates the need for invasive head or body stabilizationframes.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is aglobal leader in the field of radiosurgery dedicated to providing an improvedquality of life and a non-surgical treatment option for those diagnosed withcancer. Accuray develops and markets the CyberKnife Robotic RadiosurgerySystem, which extends the benefits of radiosurgery to include extracranialtumors, including those in the spine, lung, prostate, liver and pancreas. Todate, the CyberKnife System has been used to treat more than 50,000 patientsworldwide and currently more than 140 systems have been installed in leadinghospitals in the Americas, Europe and Asia. For more information, please visithttp://www.accuray.com.
SOURCE Accuray Incorporated
